Cargando…
Estimating the costs of genomic sequencing in cancer control
BACKGROUND: Despite the rapid uptake of genomic technologies within cancer care, few studies provide detailed information on the costs of sequencing across different applications. The objective of the study was to examine and categorise the complete costs involved in genomic sequencing for a range o...
Autores principales: | Gordon, Louisa G., White, Nicole M., Elliott, Thomas M., Nones, Katia, Beckhouse, Anthony G., Rodriguez-Acevedo, Astrid J., Webb, Penelope M., Lee, Xing J., Graves, Nicholas, Schofield, Deborah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268398/ https://www.ncbi.nlm.nih.gov/pubmed/32493298 http://dx.doi.org/10.1186/s12913-020-05318-y |
Ejemplares similares
-
Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia
por: Gordon, Louisa G., et al.
Publicado: (2022) -
The return to work experiences of middle-aged Australian workers diagnosed with colorectal cancer: a matched cohort study
por: Gordon, Louisa G, et al.
Publicado: (2014) -
The Working After Cancer Study (WACS): a population-based study of middle-aged workers diagnosed with colorectal cancer and their return to work experiences
por: Gordon, Louisa G, et al.
Publicado: (2011) -
Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021
por: Gordon, Louisa G., et al.
Publicado: (2022) -
Modelling the healthcare costs of skin cancer in South Africa
por: Gordon, Louisa G., et al.
Publicado: (2016)